BackgroundCheck.run
Search For

Bill R Reisdorph, 682506 Kimberley Rd, Ann Arbor, MI 48104

Known as:
Bill Randall Reisdorph Bill A Reisdorph Billy Randall Reisdorph Billy R Reisdorph Billy Living Reisdorph William R Reisdorph Bill R Riesdorph

Bill Reisdorph Phones & Addresses

2506 Kimberley Rd, Ann Arbor, MI 48104    734-6627945    734-6652741    734-2162196   

Archer, FL   

2506 Kimberley Rd, Ann Arbor, MI 48104    734-3958806   

Social networks

Bill R Reisdorph

Linkedin

Work

Company: University of michigan Apr 2017 Position: Adjunct clinical assistant professor

Education

School / High School: Hartley High School

Skills

Leadership • Team Building • Clinical Trials • Ind and Ide Preparation and Support • Public Speaking • Pharmaceutical Manufacturing • Clinical Research • Biotechnology • Regulatory Affairs • Life Sciences • Validation • Strategic Planning • Drug Discovery • Microsoft Office • Lifesciences • Drug Development • Clinical Development • Regulatory Submissions • Cmc Development • Medicinal Chemistry • Cmc • Project Management • Regulatory Guidelines • Drug Discovery and Development • Pharmaceutical Industry • Technology Transfer • Cmc Regulatory Affairs • Fda • Sop • Ind • Synthesis of Apis

Ranks

Certificate: Regulatory Affairs Certification Rac

Industries

Pharmaceuticals
Get Report
Control this profile

Mentions for Bill R Reisdorph

Bill Reisdorph resumes & CV records

Resumes

Bill Reisdorph Photo 10

Owner And President

Location:
Hartley, TX
Industry:
Pharmaceuticals
Work:
University of Michigan
Adjunct Clinical Assistant Professor Regulatory Affairs Associates 2004 - 2016
Consultant and Senior Project Manager University of Michigan Medical School 2004 - 2016
Regulatory Project Manager and Clinical Research Reisdorph Scientific Consulting 2004 - 2016
Owner and President Pfizer 2000 - 2004
Cmc Regulatory Affairs Associate Parke-Davis Pharmaceutical Research 1991 - 2000
Drug Discovery Chemist and Cmc Auditor Center For Drug Discovery 1989 - 1991
Research and Teaching Assistant Farchan Chemical Research 1988 - 1989
Assistant Research Chemist and Scale-Up Pharmatec Pakistan (Pvt) Ltd 1987 - 1988
Research and Production and Scale-Up Chemist Modern Aromatics 1984 - 1986
Owner and Entrepeneur Peninsular Chemical Research 1976 - 1979
Chemical Technician
Education:
Hartley High School
University of Florida
Bachelors, Bachelor of Science, Organic Chemistry University of Florida
Master of Science, Masters, Design, Chemistry, Pharmacy
Skills:
Leadership, Team Building, Clinical Trials, Ind and Ide Preparation and Support, Public Speaking, Pharmaceutical Manufacturing, Clinical Research, Biotechnology, Regulatory Affairs, Life Sciences, Validation, Strategic Planning, Drug Discovery, Microsoft Office, Lifesciences, Drug Development, Clinical Development, Regulatory Submissions, Cmc Development, Medicinal Chemistry, Cmc, Project Management, Regulatory Guidelines, Drug Discovery and Development, Pharmaceutical Industry, Technology Transfer, Cmc Regulatory Affairs, Fda, Sop, Ind, Synthesis of Apis
Certifications:
Regulatory Affairs Certification Rac
Raps

Publications & IP owners

Us Patents

Butenolide Endothelin Antagonists

US Patent:
5922759, Jul 13, 1999
Filed:
Dec 15, 1997
Appl. No.:
8/981059
Inventors:
William C. Patt - Chelsea MI
Bill R. Reisdorph - Ann Arbor MI
Joseph T. Repine - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31365
C07D30758
US Classification:
514464
Abstract:
Novel nonpeptides characterized as having a carbarimic group which are antagonists of endothelin I are described, as well as methods for their preparation and pharmaceutical compositions containing the same. The compounds as useful in treating elevated levels of endothelin and are therefore used in the treatment of hypertension, myocardial infarction, diabetes, cerebral vasospasm, cirrhosis, septic shock, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, chronic and acute renal failure, preeclamnpsia, atherosclerotic disorders including Raynaud's disease and restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, stroke, head injury, and ischemic bowel syndrome.

Butenolide Endothelin Antagonists

US Patent:
6017951, Jan 25, 2000
Filed:
Feb 10, 1999
Appl. No.:
9/247534
Inventors:
William C. Patt - Chelsea MI
Bill R. Reisdorph - Ann Arbor MI
Joseph T. Repine - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31335
C07D30732
US Classification:
514464
Abstract:
Novel nonpeptides characterized as having a carbamic group which are antagonists of endothelin I are described, as well as methods for their preparation and pharmaceutical compositions containing the same. The compounds are useful in treating elevated levels of endothelin and are therefore useful in the treatment of hypertension, myocardial infarction, diabetes, cerebral vasospasm, cirrhosis, septic shock, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythminas, asthma, chronic and acute renal failure, preeclampsia, atherosclerotic disorders including Raynaud's disease and restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, stroke, head injury, and ischemic bowel syndrome.

Possible Relatives

Jason L Reisdorph  Kent B Reisdorph  Brenda M Reisdorph  Charles B Reisdorph  Bill Johnson  Bill A Stancill  Bill W Standley  Bill E Stanford  Bill White  Bill J Jones 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.